Published Papers & Misc - MAEHARA Taketoshi

41. Sakyo Hirai, Motoki Inaji, Yoji Tanaka, Shoko Hara, Tadashi Nariai, Taketoshi Maehara. Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease. J Stroke Cerebrovasc Dis. 2017.12; 26 (12): 2814-2820. ( PubMed, DOI )

42. Miyajima M., Fujiwara K., Toshitaka Y., Yoko S., Sasai-Sakuma T., Kano M., Maehara T., Watanabe Y., Watanabe S., Murata Y., Sasano T., Eisuke M.. Seizure prediction in localization-related epilepsy by heart rate variability monitoring JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 554-555. ( DOI )

43. Jiro Aoyama, Tadashi Nariai, Maki Mukawa, Motoki Inaji, Yoji Tanaka, Taketoshi Maehara. Case of Familial Moyamoya Disease Presenting 10 Years After Initial Negative Magnetic Resonance Screening in Childhood. World Neurosurg. 2017.09; 105 1035.e1-1035.e4. ( PubMed, DOI )

44. Imai Ayano, Takase Hiroshi, Imadome Ken-ichi, Matsuda Go, Ohnishi Iichiro, Yamamoto Kouhei, Kudo Takumi, Tanaka Yoji, Maehara Taketoshi, Miura Osamu, Arai Ayako. Epstein-Barrウイルス陽性ブドウ膜炎の発症後に小脳に生じた節外性鼻型NK/T細胞リンパ腫(Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis) Internal Medicine. 2017.06; 56 (11): 1409-1414. ( ichushi )

45. Xiaoshu Dong, Kaoru Tamura, Daisuke Kobayashi, Noboru Ando, Kazutaka Sumita, Taketoshi Maehara. LAPTM4B-35 is a novel prognostic factor for glioblastoma. J. Neurooncol.. 2017.04; 132 (2): 295-303. ( PubMed, DOI )

46. Xiaoshu Dong, Kaoru Tamura, Daisuke Kobayashi, Noboru Ando, Kazutaka Sumita, Taketoshi Maehara. Erratum to: LAPTM4B-35 is a novel prognostic factor for glioblastoma. J. Neurooncol.. 2017.04; 132 (2): 305-306. ( PubMed, DOI )

47. S Hara, Y Tanaka, Y Ueda, S Hayashi, M Inaji, K Ishiwata, K Ishii, T Maehara, T Nariai. O-Gas PET and DSC-MRI. AJNR Am J Neuroradiol. 2017.04; 38 (4): 696-702. ( PubMed, DOI )

48. Baba Shimpei, Sugawara Yuji, Moriyama Kengo, Inaji Motoki, Maehara Taketoshi, Yamamoto Toshiyuki, Morio Tomohiro. CDKL5突然変異を有する女児における迷走神経刺激補助療法による難治性てんかんの改善(Amelioration of intractable epilepsy by adjunct vagus nerve stimulation therapy in a girl with a CDKL5 mutation) Brain & Development. 2017.04; 39 (4): 341-344. ( ichushi )

49. Taishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, Jun Nakabayashi, Kazuhiro Tanaka, Kaoru Tamura, Kensuke Tateishi, Manabu Kinoshita, Shintaro Fukushima, Hirokazu Takami, Kohei Fukuoka, Kai Yamazaki, Yuko Matsushita, Makoto Ohno, Yasuji Miyakita, Soichiro Shibui, Atsuhiko Kubo, Takashi Shuto, Sylvia Kocialkowski, Shoji Yamanaka, Akitake Mukasa, Takashi Sasayama, Kazuhiko Mishima, Taketoshi Maehara, Nobutaka Kawahara, Motoo Nagane, Yoshitaka Narita, Hiroyuki Mano, Toshikazu Ushijima, Koichi Ichimura. Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma. Acta Neuropathol.. 2017.02; 133 (2): 321-324. ( PubMed, DOI )

50. Hirota Shin, Inaji Motoki, Nariai Tadashi, Hara Mutsuya, Tamaki Masashi, Maehara Taketoshi, Tomita Hiroki, Tone Osamu. びまん性軸索損傷患者における認知障害と雇用状態との関連性について(Correlations between Cognitive Impairments and Employment Status in Patients with Diffuse Axonal Injury) Neurologia medico-chirurgica. 2017.02; 57 (2): 94-100. ( ichushi )

51. Takahiro Ogishima, Kaoru Tamura, Daisuke Kobayashi, Motoki Inaji, Shihori Hayashi, Reina Tamura, Tadashi Nariai, Kenji Ishii, Taketoshi Maehara. ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations. Brain Tumor Pathol. 2017.01; 34 (1): 20-27. ( PubMed, DOI )

52. Maki Mukawa, Tadashi Nariai, Hideaki Onda, Taku Yoneyama, Yasuo Aihara, Kengo Hirota, Takumi Kudo, Kazutaka Sumita, Taketoshi Maehara, Takakazu Kawamata, Hidetoshi Kasuya, Hiroyuki Akagawa. Exome Sequencing Identified CCER2 as a Novel Candidate Gene for Moyamoya Disease. J Stroke Cerebrovasc Dis. 2017.01; 26 (1): 150-161. ( PubMed, DOI )

53. Ogishima Takahiro, Tamura Kaoru, Kobayashi Daisuke, Inaji Motoki, Hayashi Shihori, Tamura Reina, Nariai Tadashi, Ishii Kenji, Maehara Taketoshi. ATRXステータスはIDH1変異を伴うWHOグレードII/IIIグリオーマにおける11C-メチオニン取り込みと相関する(ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations) Brain Tumor Pathology. 2017.01; 34 (1): 20-27. ( ichushi )

54. Imai Ayano, Takase Hiroshi, Imadome Ken-Ichi, Matsuda Go, Ohnishi Iichiro, Yamamoto Kouhei, Kudo Takumi, Tanaka Yoji, Maehara Taketoshi, Miura Osamu, Arai Ayako. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis INTERNAL MEDICINE. 2017; 56 (11): 1409-1414. ( PubMed, DOI )

55. Shin Hirota, Motoki Inaji, Tadashi Nariai, Mutsuya Hara, Masashi Tamaki, Taketoshi Maehara, Hiroki Tomita, Osamu Tone. Correlations between Cognitive Impairments and Employment Status in Patients with Diffuse Axonal Injury. Neurol. Med. Chir. (Tokyo). 2016.12; ( PubMed, DOI )

56. Shimpei Baba, Yuji Sugawara, Kengo Moriyama, Motoki Inaji, Taketoshi Maehara, Toshiyuki Yamamoto, Tomohiro Morio. Amelioration of intractable epilepsy by adjunct vagus nerve stimulation therapy in a girl with a CDKL5 mutation. Brain Dev.. 2016.11; ( PubMed, DOI )

57. Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Asanao Shimokawa, Hirokazu Takami, Shota Tanaka, Akitake Mukasa, Mitsuaki Shirahata, Saki Shimizu, Kaori Suzuki, Kuniaki Saito, Keiichi Kobayashi, Fumi Higuchi, Takeo Uzuka, Ryohei Otani, Kaoru Tamura, Kazutaka Sumita, Makoto Ohno, Yasuji Miyakita, Naoki Kagawa, Naoya Hashimoto, Ryusuke Hatae, Koji Yoshimoto, Naoki Shinojima, Hideo Nakamura, Yonehiro Kanemura, Yoshiko Okita, Manabu Kinoshita, Kenichi Ishibashi, Tomoko Shofuda, Yoshinori Kodama, Kanji Mori, Yusuke Tomogane, Junya Fukai, Koji Fujita, Yuzo Terakawa, Naohiro Tsuyuguchi, Shusuke Moriuchi, Masahiro Nonaka, Hiroyoshi Suzuki, Makoto Shibuya, Taketoshi Maehara, Nobuhito Saito, Motoo Nagane, Nobutaka Kawahara, Keisuke Ueki, Toshiki Yoshimine, Etsuo Miyaoka, Ryo Nishikawa, Takashi Komori, Yoshitaka Narita, Koichi Ichimura. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016.08; 4 (1): 79. ( PubMed, DOI )

58. Koichi Ichimura, Shintaro Fukushima, Yasushi Totoki, Yuko Matsushita, Ayaka Otsuka, Arata Tomiyama, Tohru Niwa, Hirokazu Takami, Taishi Nakamura, Tomonari Suzuki, Kohei Fukuoka, Takaaki Yanagisawa, Kazuhiko Mishima, Yoichi Nakazato, Fumie Hosoda, Yoshitaka Narita, Soichiro Shibui, Akihiko Yoshida, Akitake Mukasa, Nobuhito Saito, Toshihiro Kumabe, Masayuki Kanamori, Teiji Tominaga, Keiichi Kobayashi, Saki Shimizu, Motoo Nagane, Toshihiko Iuchi, Masahiro Mizoguchi, Koji Yoshimoto, Kaoru Tamura, Taketoshi Maehara, Kazuhiko Sugiyama, Mitsutoshi Nakada, Keiichi Sakai, Yonehiro Kanemura, Masahiro Nonaka, Akio Asai, Kiyotaka Yokogami, Hideo Takeshima, Nobutaka Kawahara, Tatsuya Takayama, Masahiro Yao, Mamoru Kato, Hiromi Nakamura, Natsuko Hama, Ryuichi Sakai, Toshikazu Ushijima, Masao Matsutani, Tatsuhiro Shibata, Ryo Nishikawa, . Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Acta Neuropathol.. 2016.06; 131 (6): 889-901. ( PubMed, DOI )

59. Nobuo Sanjo, Satoko Kina, Yukiko Shishido-Hara, Yurie Nose, Satoru Ishibashi, Tetsuya Fukuda, Taketoshi Maehara, Yoshinobu Eishi, Hidehiro Mizusawa, Takanori Yokota. Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment. Intern. Med.. 2016; 55 (12): 1631-1635. ( PubMed, DOI )

60. Koichi Fujiwara, Miho Miyajima, Toshitaka Yamakawa, Erika Abe, Yoko Suzuki, Yuriko Sawada, Manabu Kano, Taketoshi Maehara, Katsuya Ohta, Taeko Sasai-Sakuma, Tetsuo Sasano, Masato Matsuura, Eisuke Matsushima. Epileptic Seizure Prediction Based on Multivariate Statistical Process Control of Heart Rate Variability Features. IEEE Trans Biomed Eng. 2015.12; ( PubMed, DOI )